| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |